Published by Josh White on 21st April 2022
(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).
URL: http://www.digitallook.com/dl/news/story/32620512/...